Salivary gland ultrasound in the diagnostic workup of juvenile Sjögren’s syndrome and mixed connective tissue disease

由 Krumrey-Langkammerer, Manuela, Haas, Johannes-Peter
發表在 Pediatr Rheumatol Online J (2020)

Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis

由 Hügle, Boris, Speth, Fabian, Haas, Johannes-Peter
發表在 Pediatr Rheumatol Online J (2017)

Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems

由 Hugle, Boris, Haas, Johannes-Peter, Benseler, Susanne M
出版 2013

Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immun...

由 Speth, Fabian, Haas, Johannes-Peter, Hinze, Claas H.
發表在 Pediatr Rheumatol Online J (2016)

Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists

由 Hinze, Claas H., Speth, Fabian, Oommen, Prasad T., Haas, Johannes-Peter
發表在 Pediatr Rheumatol Online J (2018)

Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course

由 Hügle, Boris, Hinze, Claas, Lainka, Elke, Fischer, Nadine, Haas, Johannes-Peter
出版 2014

Pathophysiology of juvenile idiopathic arthritis induced pes planovalgus in static and walking condition—A functional view using 3d gait analysis

由 Merker, Josephine, Hartmann, Matthias, Kreuzpointner, Florian, Schwirtz, Ansgar, Haas, Johannes-Peter
發表在 Pediatr Rheumatol Online J (2015)

Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list

由 Speth, Fabian, Hinze, Claas H., Andel, Susanne, Mertens, Thomas, Haas, Johannes-Peter
發表在 Pediatr Rheumatol Online J (2018)

Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results

由 Höfel, Lea, Eppler, Bruno, Storf, Magdalena, Schnöbel-Müller, Elizabeth, Haas, Johannes-Peter, Hügle, Boris
發表在 Pediatr Rheumatol Online J (2018)

Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case–control study

由 Barth, Swaantje, Schlichtiger, Jenny, Bisdorff, Betty, Hügle, Boris, Michels, Hartmut, Radon, Katja, Haas, Johannes-Peter
發表在 Pediatr Rheumatol Online J (2016)

Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis

由 Scheuern, Andrea, Fischer, Nadine, McDonald, Joseph, Brunner, Hermine I., Haas, Johannes-Peter, Hügle, Boris
發表在 Pediatr Rheumatol Online J (2016)

Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nation...

由 Heiligenhaus, Arnd, Klotsche, Jens, Niewerth, Martina, Horneff, Gerd, Ganser, Gerd, Haas, Johannes-Peter, Minden, Kirsten
發表在 Arthritis Res Ther (2020)

Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-study

由 Kersten, Ines, Lange, Anja Erika, Haas, Johannes Peter, Fusch, Christoph, Lode, Holger, Hoffmann, Wolfgang, Thyrian, Jochen Rene
出版 2014

Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population

由 Barth, Swaantje, Haas, Johannes-Peter, Schlichtiger, Jenny, Molz, Johannes, Bisdorff, Betty, Michels, Hartmut, Hügle, Boris, Radon, Katja
發表在 PLoS One (2016)

Education and employment in patients with juvenile idiopathic arthritis – a standardized comparison to the German general population

由 Schlichtiger, Jenny, Haas, Johannes-Peter, Barth, Swaantje, Bisdorff, Betty, Hager, Lisa, Michels, Hartmut, Hügle, Boris, Radon, Katja
發表在 Pediatr Rheumatol Online J (2017)

Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis

由 Klotsche, Jens, Klein, Ariane, Niewerth, Martina, Hoff, Paula, Windschall, Daniel, Foeldvari, Ivan, Haas, Johannes-Peter, Horneff, Gerd, Minden, Kirsten
發表在 Arthritis Res Ther (2021)

The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception...

由 Sengler, Claudia, Klotsche, Jens, Niewerth, Martina, Liedmann, Ina, Föll, Dirk, Heiligenhaus, Arnd, Ganser, Gerd, Horneff, Gerd, Haas, Johannes-Peter, Minden, Kirsten
發表在 RMD Open (2015)

Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab

由 Horneff, Gerd, Klein, Ariane, Klotsche, Jens, Minden, Kirsten, Huppertz, Hans-Iko, Weller-Heinemann, Frank, Kuemmerle-Deschner, Jasmin, Haas, Johannes-Peter, Hospach, Anton
發表在 Arthritis Res Ther (2016)

Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis

由 Hügle, Boris, Schippers, Anastasia, Fischer, Nadine, Ohl, Kim, Denecke, Bernd, Ticconi, Fabio, Vastert, Bas, Costa, Ivan G., Haas, Johannes-Peter, Tenbrock, Klaus
發表在 Arthritis Res Ther (2018)

The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German...

由 Listing, Miriam, Mönkemöller, Kirsten, Liedmann, Ina, Niewerth, Martina, Sengler, Claudia, Listing, Joachim, Foell, Dirk, Heiligenhaus, Arnd, Klein, Ariane, Horneff, Gerd, Ganser, Gerd, Haas, Johannes-Peter, Klotsche, Jens, Minden, Kirsten
發表在 Arthritis Res Ther (2018)